BlossomHill Therapeutics, Inc. Common Stock (BLSM) Stock
Key stats
- Market cap
- $512.37M
- Price / Earnings ratio
- -7.5x
- EPS (TTM)
- -$5.30
- Volume
- Loading
- 52-week high
- $27.99
- 52-week low
- $11.02
Source: third-party data provider, as of November 13, 2026
Compare with BLSM
Technical indicators
- RSI 14
- 53.38
- MACD 12/26/9
- -0.92
- EMA 9 of MACD
- -1.23
- MACD histogram
- 0.30
- SMA 50
- $18.22
- Price below SMA 50
- EMA 50
- $16.70
- Price below EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
About BlossomHill Therapeutics, Inc. Common Stock
BlossomHill Therapeutics is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop innovative small molecule medicines that address significant unmet medical needs in cancer treatment.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Jingrong Jean Cui Ph.D. | Scientific Founder, President, CEO & Director | 1963 |
| Dr. Yishan Li M.B.A., Ph.D. | Co-Founder & Executive Chairman | 1965 |
| Mr. Jason A. Keyes M.B.A. | CFO & Executive VP | 1971 |
| Dr. Geoff Oxnard M.D. | Chief Medical Officer & Executive VP | 1977 |
| Dr. Vincent Liptak J.D., M.B.A., Ph.D. | General Counsel & Executive VP | 1971 |
| Dr. Zachary F. Zimmerman M.D., Ph.D. | Senior Vice President of Clinical Development | — |
| Dr. Eugene Y. Rui Ph.D. | Senior Vice President of Chemistry | — |
| Dr. Z. Jesse Shao Ph.D., R.Ph. | Senior Vice President of CMC | — |
| Dr. Ashley Preston Ph.D. | Senior VP and Head of Regulatory Affairs & Quality Assurance | — |
| Dr. Antonio Garrido-Montalban Ph.D. | Senior Vice President of Drug Substance | — |
Fundamentals
Valuation
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 53.38
- MACD 12/26/9
- -0.92
- EMA 9 of MACD
- -1.23
- MACD histogram
- 0.30
- SMA 50
- $18.22
- Price below SMA 50
- EMA 50
- $16.70
- Price below EMA 50
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $28.00
- Average
- $33.25
- High
- $40.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +14.4 | -1.8 | -26.0 | +29.8 |




